本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Aura Biosciences, Inc.

5.71
+0.14002.51%
盘前5.720.0100+0.18%08:29 EDT
成交量:12.39万
成交额:70.47万
市值:2.87亿
市盈率:-3.26
高:5.86
开:5.61
低:5.53
收:5.57
数据加载中...
2024/02/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/07

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/08

重要事件披露

Form 8-K - Current report
2024/01/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/12

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/11/09

重要事件披露

Form 8-K - Current report
2023/11/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/09

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/06

重要事件披露

Form 8-K - Current report
2023/11/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/10/02

重要事件披露

Form 8-K - Current report